BMS Gets US Approval Of Ozanimod For Relapsing MS, But Launch Delayed

 
• By Joseph Haas
  
3d illustration of nerve cells, concept for Neurological Diseases, tumors and brain surgery.
BMS says Zeposia offers a new treatment option for relapsing MS patients
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip